| Product Code: ETC9956196 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Tasigna Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Tasigna Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Tasigna Market - Industry Life Cycle |
3.4 United Kingdom (UK) Tasigna Market - Porter's Five Forces |
3.5 United Kingdom (UK) Tasigna Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Tasigna Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Tasigna Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in the United Kingdom |
4.2.2 Growing awareness and adoption of targeted therapies like Tasigna |
4.2.3 Favorable reimbursement policies for cancer treatments in the UK |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new drugs |
4.3.2 Competition from other existing and emerging treatments for CML |
4.3.3 Potential side effects and safety concerns associated with Tasigna |
5 United Kingdom (UK) Tasigna Market Trends |
6 United Kingdom (UK) Tasigna Market, By Types |
6.1 United Kingdom (UK) Tasigna Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Tasigna Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Tasigna Market Revenues & Volume, By 200 mg Capsule, 2021- 2031F |
6.1.4 United Kingdom (UK) Tasigna Market Revenues & Volume, By 150 mg Capsule, 2021- 2031F |
6.2 United Kingdom (UK) Tasigna Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Tasigna Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 United Kingdom (UK) Tasigna Market Revenues & Volume, By Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Tasigna Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Tasigna Market Export to Major Countries |
7.2 United Kingdom (UK) Tasigna Market Imports from Major Countries |
8 United Kingdom (UK) Tasigna Market Key Performance Indicators |
8.1 Patient adherence rates to Tasigna treatment regimen |
8.2 Average time from diagnosis to initiation of Tasigna therapy |
8.3 Number of healthcare providers trained in prescribing and managing Tasigna therapy |
9 United Kingdom (UK) Tasigna Market - Opportunity Assessment |
9.1 United Kingdom (UK) Tasigna Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Tasigna Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Tasigna Market - Competitive Landscape |
10.1 United Kingdom (UK) Tasigna Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Tasigna Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here